Skip to content

Predicting the Outcome of a Demyelinating event

Predicting the Outcome of a Demyelinating event - PROUD Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON43788
Enrollment
1500
Registered
2006-08-24
Start date
2006-11-15
Completion date
Unknown
Last updated
2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MS Multiple Sclerosis

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: For patients: 1. Patients with a Clinically Isolated Syndrome (CIS) suggestive of central nervous system demyelination involving the optic nerve, brainstem or spinal cord. 2. Age > 18 years en

Exclusion criteria

Exclusion criteria: For patients and controls: Sever co-morbidity like AIDS, cancer or other severe diseases with shortening life expectance

Design outcomes

Primary

MeasureTime frame
Is there an association between clinical, immunological and infection parameters and progression to MS after a first event of demyelination.

Secondary

MeasureTime frame
- Are current diagnostic McDonald criteria also valid for clinically isolated syndromes in typical neurological practice (non-academic) settings? - Are certain single nucleotide polymorphisms (SNP*s) over represented in the subgroup progressing to clinically definite MS or associated with benign/aggressive courses?

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)